Literature DB >> 30009333

The serum level of inflammatory markers in chronic and episodic migraine: a case-control study.

Fahimeh Martami1,2, Soodeh Razeghi Jahromi1,2, Mansoureh Togha3, Zeinab Ghorbani1,4, Maryam Seifishahpar1,2, Atoosa Saidpour2.   

Abstract

The exact mechanism of the migraine pathophysiology remained unclear. Although there are some reports showing low-grade inflammation in migraineurs, further studies are needed in this field. Thus, we designed a study to evaluate the serum levels of two main proinflammatory markers in migraine patients. In this case-control research, 43 migraine patients (23 chronic and 20 episodic migraineurs) and 40 age-sex-matched headache-free controls were studied. Demographic, dietary, and anthropometric data, headache characteristics, and serum C-reactive proteins (CRP) and tumor necrosis factor-alpha (TNF-α) assessments were collected. The mean ± SD age of the case and control groups were 36.98 ± 9.91 and 34.84 ± 9.75 years respectively. Compared to control subjects, both episodic and chronic migraineurs had significantly higher median levels of TNF-α (0.24, 0.95, and 1.90 pg/ml, respectively; P value < 0.001). Also, we observed a positive association between the TNF-α levels and the odds of having migraine after considering gender, age, body mass index, and dietary intakes of energy, carbohydrate, protein, fat, and mono and poly unsaturated fatty acids in the multivariable regression models (OR = 2.15; 95% CI 1.31-3.52; P value < 0.001). However, no significant association was demonstrated between migraine and serum CRP (OR = 2.91; 95% CI 0.87-9.78; P value = 0.08). These findings supported that inflammatory state could be related to the pathogenesis of migraine and it can thus be suggested that this effect might be beyond migraine progression. Further detailed studies are needed to investigate the importance of these findings in the pathogenesis of migraine headache.

Entities:  

Keywords:  C-reactive proteins (CRP); Headache; Inflammation; Migraine; Tumor necrosis factor-alpha (TNF-α)

Mesh:

Substances:

Year:  2018        PMID: 30009333     DOI: 10.1007/s10072-018-3493-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  48 in total

1.  Immunoglobulin and complement studies in migraine.

Authors:  G D Lord; J W Duckworth
Journal:  Headache       Date:  1977-09       Impact factor: 5.887

2.  Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis.

Authors:  Sherifa A Hamed; Enas A Hamed; Azza M Ezz Eldin; Nagia M Mahmoud
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-03       Impact factor: 2.136

Review 3.  Neurogenic inflammation and migraine: implications for the therapeutics.

Authors:  Stephen J Peroutka
Journal:  Mol Interv       Date:  2005-10

4.  Endothelial function in patients with migraine during the interictal period.

Authors:  Federico A Silva; Christian F Rueda-Clausen; Sandra Y Silva; Juan G Zarruk; Juan C Guzmán; Carlos A Morillo; Boris Vesga; Gustavo Pradilla; Mildred Flórez; Patricio López-Jaramillo
Journal:  Headache       Date:  2007-01       Impact factor: 5.887

5.  Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study.

Authors:  Marco Túlio A Tanure; Rodrigo S Gomez; Rubens Carlos L Hurtado; Antônio L Teixeira; Renan Barros Domingues
Journal:  J Headache Pain       Date:  2010-06-17       Impact factor: 7.277

6.  Association of serum levels of intercellular adhesion molecule-1 and interleukin-6 with migraine.

Authors:  Fengzhi Wang; Qiu He; Zhanxiu Ren; Fuyong Li; Wei Chen; Xiang Lin; Hemin Zhang; Guofeng Tai
Journal:  Neurol Sci       Date:  2014-11-23       Impact factor: 3.307

Review 7.  An overview on immune system and migraine.

Authors:  P P Bruno; F Carpino; G Carpino; A Zicari
Journal:  Eur Rev Med Pharmacol Sci       Date:  2007 Jul-Aug       Impact factor: 3.507

8.  Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.

Authors:  Daniel Serrano; Aubrey N Manack; Michael L Reed; Dawn C Buse; Sepideh F Varon; Richard B Lipton
Journal:  Value Health       Date:  2013 Jan-Feb       Impact factor: 5.725

9.  C-reactive protein may be increased in migraine patients who present with complex clinical features.

Authors:  K M A Welch; Avery W Brandes; Lauren Salerno; Jan Lewis Brandes
Journal:  Headache       Date:  2006-02       Impact factor: 5.887

10.  GBD 2015: migraine is the third cause of disability in under 50s.

Authors:  Timothy J Steiner; Lars J Stovner; Theo Vos
Journal:  J Headache Pain       Date:  2016-11-14       Impact factor: 7.277

View more
  14 in total

1.  Severe periodontitis is linked with increased peripheral levels of sTWEAK and PTX3 in chronic migraineurs.

Authors:  Yago Leira; Pablo Ameijeira; Clara Domínguez; Esteban López-Arias; Paulo Ávila-Gómez; María Pérez-Mato; Tomás Sobrino; Francisco Campos; Francesco D'Aiuto; Rogelio Leira; Juan Blanco
Journal:  Clin Oral Investig       Date:  2019-05-20       Impact factor: 3.573

2.  Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.

Authors:  Anne-Sophie Wattiez; Levi P Sowers; Andrew F Russo
Journal:  Expert Opin Ther Targets       Date:  2020-02-13       Impact factor: 6.902

3.  Roxadustat alleviates nitroglycerin-induced migraine in mice by regulating HIF-1α/NF-κB/inflammation pathway.

Authors:  Dai-Gang Yang; Yong-Yao Gao; Ze-Qun Yin; Xue-Rui Wang; Xian-She Meng; Ting-Feng Zou; Ya-Jun Duan; Yuan-Li Chen; Chen-Zhong Liao; Zhou-Ling Xie; Xiao-Dong Fan; Lu Sun; Ji-Hong Han; Xiao-Xiao Yang
Journal:  Acta Pharmacol Sin       Date:  2022-08-10       Impact factor: 7.169

4.  Vitamin D in migraine headache: a comprehensive review on literature.

Authors:  Zeinab Ghorbani; Mansoureh Togha; Pegah Rafiee; Zeynab Sadat Ahmadi; Reyhaneh Rasekh Magham; Samane Haghighi; Soodeh Razeghi Jahromi; Maryam Mahmoudi
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

5.  Evaluation of serum uric levels in migraine.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Ali Aygün; Volkan Karabacak; Yavuz Altunkaynak; Dursun Kirbaş
Journal:  Neurol Sci       Date:  2020-07-20       Impact factor: 3.307

6.  Salivary inflammatory markers in tension type headache and migraine: the SalHead cohort study.

Authors:  Anastasia Bougea; Nikolaos Spantideas; Petros Galanis; Paraskevi Katsika; Fotini Boufidou; Panagiota Voskou; Ioannis Vamvakaris; Evangelos Anagnostou; Xrysa Nikolaou; Evangelia Kararizou
Journal:  Neurol Sci       Date:  2019-12-10       Impact factor: 3.307

Review 7.  Association of diet and headache.

Authors:  Soodeh Razeghi Jahromi; Zeinab Ghorbani; Paolo Martelletti; Christian Lampl; Mansoureh Togha
Journal:  J Headache Pain       Date:  2019-11-14       Impact factor: 7.277

Review 8.  Gut-brain Axis and migraine headache: a comprehensive review.

Authors:  Mahsa Arzani; Soodeh Razeghi Jahromi; Zeinab Ghorbani; Fahimeh Vahabizad; Paolo Martelletti; Amir Ghaemi; Simona Sacco; Mansoureh Togha
Journal:  J Headache Pain       Date:  2020-02-13       Impact factor: 7.277

9.  Assessing the Effect of Zinc Supplementation on the Frequency of Migraine Attack, Duration, Severity, Lipid Profile and hs-CRP in Adult Women.

Authors:  Monireh Mazaheri; Arash Mosarrezaii Aghdam; Mohammad Heidari; Rasoul Zarrin
Journal:  Clin Nutr Res       Date:  2021-04-27

10.  Association of Migraine with Its Comorbidities and Food Specific Immunoglobulin G Antibodies and Inflammatory Cytokines: Cross-Sectional Clinical Research.

Authors:  Zhiming Zhao; Huiwen Jin; Yang Yin; Yanwei Hou; Jingyan Wang; Chunling Tang; Jun Fu
Journal:  J Pain Res       Date:  2021-08-05       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.